The Valley Desk

NCT03611868 · Interventional trial

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Cutaneous Melanoma, MDM2 Gene Mutation, Malignant Peripheral Nerve Sheath Tumors (MPNST), Melanoma, Mucosal Melanoma, P53 Mutation, Unresectable or Metastatic Melanoma or Advanced Solid Tumors, Uveal Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov